What's new in azithromyin?
Figures
Similar articles
-
Dermatologic therapy--1960. What's new? and what's true of what's new?Acta Derm Venereol. 1961;41:187-93. Acta Derm Venereol. 1961. PMID: 13690908 No abstract available.
-
What's new and what's true of what's new in dermatology.Calif Med. 1955 Jul;83(1):1-5. Calif Med. 1955. PMID: 14390001 Free PMC article. No abstract available.
-
The Editor's Workshop: Pediatric and adolescent gynecology: What's the issue? What's the answer? What's the big picture? What's the national perspective?J Pediatr Adolesc Gynecol. 2009 Aug;22(4):195-6. doi: 10.1016/j.jpag.2009.06.001. J Pediatr Adolesc Gynecol. 2009. PMID: 19646664 No abstract available.
-
Update on health care in Canada: what's right, what's wrong, what's left.J Public Health Policy. 1998;19(3):267-88. J Public Health Policy. 1998. PMID: 9798371 Review.
-
[What's essential, what's useful and what's superfluous in patients with dilated cardiomyopathy].Ital Heart J. 2005 May;6 Suppl 2:28S-34S. Ital Heart J. 2005. PMID: 15945335 Review. Italian. No abstract available.
Cited by
-
Acceptability of azithromycin for the control of trachoma in Northern Tanzania.Trans R Soc Trop Med Hyg. 2005 Sep;99(9):656-63. doi: 10.1016/j.trstmh.2005.03.006. Trans R Soc Trop Med Hyg. 2005. PMID: 15979657 Free PMC article.
-
Using a case study approach to document 'preferred practices' in mass drug administration for trachoma.Community Eye Health. 2014;27(88):s01-2. Community Eye Health. 2014. PMID: 26113781 Free PMC article. No abstract available.
-
Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis.Antimicrob Agents Chemother. 2005 Nov;49(11):4804-6. doi: 10.1128/AAC.49.11.4804-4806.2005. Antimicrob Agents Chemother. 2005. PMID: 16251338 Free PMC article.
References
-
- Bailey RL, Arullendran P, Whittle HC, et al. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 1993;342:453–6. - PubMed
-
- Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet. 1999;354:630–5. - PubMed
-
- Whitty CJ, Glasgow KW, Sadiq ST, et al. Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children. Pediatr Infect Dis J. 1999;18:955–8. - PubMed
-
- Bowman RJ, Sillah A, Van Dehn C, et al. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci. 2000;41:4074–9. - PubMed
LinkOut - more resources
Full Text Sources